Leon Cooperman’s Omega Advisors bought a huge stake in Rocket Companies in the final months of 2025. Mr. Cooperman bought more than $375 million in stock in the Detroit-based mortgage company in the fourth quarter of last year, according to regulatory filings. Rocket is currently the fund’s largest holding, valued at about $407 million, according to InsiderScore data. RKT 1Y Mountain Rocket, 1 Year Rocket stock managed to rise nearly 72% over the year, with only a slight decline in the fourth quarter of 2025. The stock price will fall 4% in 2026, but analysts surveyed by LSEG expect it to recover in the future. Most have an affirmative rating, but the average price target suggests upside potential of more than 15%. Mr. Cooperman more than doubled his stake in Occidental Petroleum to more than $28 million. The Omega family office chairman increased his position at KBR by more than 20%, making it worth more than $85 million. However, the billionaire investor reduced his holdings in Arivent Biopharma to zero. The Goldman Sachs alumnus cut his positions at DiaMedica Therapeutics and OneMain Holdings by more than 38% and 16%, respectively.
